Primary Objective: Assess overall sensitivity and specificity of Oncoguard Liver for hepatocellular cancer (HCC) detection in a surveillance population. Secondary Objective(s): Assess performance of Oncoguard Liver in confirmed HCC and non-HCC population. Assess early-stage sensitivity of Oncoguard Liver for HCC detection in a surveillance population.
What is the full name of this clinical trial?
ALTUS2021-01: ALTUS: Performance of a Multi-Target Hepatocellular Carcinoma Test in Subjects with Increased Risk
Yang, Ju Dong
N/A (Cancer Control)